High Prevalence of the Metabolic Syndrome in Iranian Adolescents* (Q58420538)

3

0 references

Parvin Mirmiran

object named as

Parvin Mirmiran

2

0 references

Ahmad Esmaillzadeh

object named as

Ahmad Esmaillzadeh

1

0 references

author name string

Fereidoun Azizi

Banting lecture 1988. Role of insulin resistance in human disease

5

0 references

publication date

March 2006

0 references

published in

Obesity

0 references

volume

14

0 references

issue

3

0 references

page(s)

377-382

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.50

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.50

Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.50

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.50

Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.50

Whole-grain consumption and the metabolic syndrome: a favorable association in Tehranian adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.50

31 March 2020

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.50

Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.50

Prevalence and trends of a metabolic syndrome phenotype among u.s. Adolescents, 1999-2000.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.50

Prevalence of overweight and obesity in adolescent Tehrani students, 2000-2001: an epidemic health problem

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.50

Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.50

Obesity and the metabolic syndrome in children and adolescents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.50

Metabolic syndrome among children and adolescents aged 10-18 years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.50

Standardized percentile curves of body mass index of Iranian children compared to the US population reference

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.50

Establishing a standard definition for child overweight and obesity worldwide: international survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.50

An accelerated nutrition transition in Iran

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.50

Development of general and central obesity from childhood into early adulthood in African American and European American males and females with a family history of cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.50

Development of fatness, fitness, and lifestyle from adolescence to the age of 36 years: determinants of the metabolic syndrome in young adults: the amsterdam growth and health longitudinal study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.50

The epidemic of obesity in American Indian communities and the need for childhood obesity-prevention programs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.50